| |
 |
|
Class Information
Number: 514/178
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system > Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description: Subject matter wherein one nuclear carbon of the cyclopentanohydrophenanthrene nucleus is bonded to an oxygen through a double bond and wherein another nuclear carbon atom of said cyclopentanohydrophenanthrene is bonded to at least one other oxygen through a single bond as, e.g., ether, hydroxy or alcoholate, etc.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7605151 |
Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
Oct. 20, 2009 |
| 7595055 |
Pharmaceutical composition comprising an extract or compounds isolated from Elfvingia applanata for the prevention and the treatment of diabetes and diabetic complications |
Sep. 29, 2009 |
| 7582622 |
Steroids having a mixed androgenic and progestagenic profile |
Sep. 1, 2009 |
| 7572779 |
Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
Aug. 11, 2009 |
| 7572780 |
Method and kit for reducing the symptoms of peripheral vascular disease |
Aug. 11, 2009 |
| 7572781 |
Prodrugs for use as ophthalmic agents |
Aug. 11, 2009 |
| 7534779 |
Quinol compound and pharmaceutical composition |
May. 19, 2009 |
| 7528123 |
Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
May. 5, 2009 |
| 7521438 |
Combination of loteprednol and .beta..sub.2-adrenoceptor agonists |
Apr. 21, 2009 |
| 7482334 |
Therapeutic treatment methods |
Jan. 27, 2009 |
| 7459445 |
Estrogenic compounds and topical pharmaceutical formulations of the same |
Dec. 2, 2008 |
| 7456161 |
Use of DHEA and DHEA-sulfate for the treatment of chronic obstructive pulmonary disease |
Nov. 25, 2008 |
| 7456160 |
Formulation |
Nov. 25, 2008 |
| 7435757 |
2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17.beta.-hydroxy steroid dehydrogenase type 1 |
Oct. 14, 2008 |
| 7419972 |
2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17.beta.-hydroxy steroid dehydrogenase type 1 |
Sep. 2, 2008 |
| 7402578 |
Methods for inhibiting cognitive deterioration in adults with down's syndrome |
Jul. 22, 2008 |
| 7388003 |
.DELTA..sup.15-D-Homosteroids with androgenic action |
Jun. 17, 2008 |
| 7371741 |
Estradiol derivatives and pharmaceutical compositions using same |
May. 13, 2008 |
| 7368442 |
Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
May. 6, 2008 |
| 7364754 |
Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same |
Apr. 29, 2008 |
| 7361645 |
Androgenic 7-substituted 11-halogen steroids |
Apr. 22, 2008 |
| 7361646 |
Methods for treating gastroesophageal reflux disease |
Apr. 22, 2008 |
| 7342004 |
Thioether sulphamate steroids as steroid inhibitors and anti-cancer compounds |
Mar. 11, 2008 |
| 7326697 |
Methods for increasing the therapeutic response to electroconvulsive therapy |
Feb. 5, 2008 |
| 7300926 |
Steroidal quinols and their use for estrogen replacement therapy |
Nov. 27, 2007 |
| RE39861 |
Methods of extended use oral contraception |
Sep. 25, 2007 |
| RE39862 |
Unsaturated 14, 15-cyclopropanoandrostanes, a method for their production and pharmaceutical compositions containing these compounds |
Sep. 25, 2007 |
| 7214672 |
Preventives/remedies for inflammatory airway diseases |
May. 8, 2007 |
| RE39592 |
Extended release growth promoting two component composition |
Apr. 24, 2007 |
| 7205288 |
Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
Apr. 17, 2007 |
| 7199116 |
Method of modulating the basal metabolic rate of a dieting mammal by administration of a metabolic modulating agent to the dieting mammal |
Apr. 3, 2007 |
| 7196074 |
Methods of making, using and pharmaceutical formulations comprising 7.alpha., 11.beta.-dimethyl-17.beta.-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
Mar. 27, 2007 |
| 7196075 |
Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
Mar. 27, 2007 |
| 7186707 |
Prodrugs for use as ophthalmic agents |
Mar. 6, 2007 |
| 7182960 |
Pharmaceutical compositions for nasal delivery of oestradiol and norethisterone |
Feb. 27, 2007 |
| 7179799 |
(3) and (6) substituted estrogenic compounds |
Feb. 20, 2007 |
| 7169768 |
Method of decreasing atherosclerosis and its complications |
Jan. 30, 2007 |
| 7169769 |
17.alpha.-hydroxy-14.beta.-steroids with hormonal effect |
Jan. 30, 2007 |
| 7160871 |
Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
Jan. 9, 2007 |
| 7157450 |
Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
Jan. 2, 2007 |
| 7119081 |
Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
Oct. 10, 2006 |
| 7098199 |
Steroid sulphatase inhibitors |
Aug. 29, 2006 |
| 7078057 |
Process for producing nanometer particles by fluid bed spray-drying |
Jul. 18, 2006 |
| 7078395 |
Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling |
Jul. 18, 2006 |
| 7056905 |
Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
Jun. 6, 2006 |
| 7053077 |
Use of biogenic estrogen sulfamates for hormone replacement therapy |
May. 30, 2006 |
| 7045513 |
DHEA composition and method |
May. 16, 2006 |
| 7045315 |
Methods for modulating expression of exogenous genes in mammalian systems |
May. 16, 2006 |
| 7037907 |
Estradiol conjugates and uses thereof |
May. 2, 2006 |
| 7030104 |
Topical oestroprogestational compositions with a systemic effect |
Apr. 18, 2006 |
|
|
|
